Skip to search formSkip to main contentSkip to account menu

Org 10172

Known as: ORG10172, Org-10172, Organon 10172 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

danaproid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Heparin-associated thrombocytopenia: Successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins
SummaryA patient suffering from heparin-associated thrombocytopenia (HAT), recurrent arteriothromboses, and acute renal failure… 
1997
1997
Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
Heparin-induced thrombocytopenia is an immuno-mediated life-threatening side effect of heparin therapy which poses difficulties… 
Review
1992
Review
1992
Orgaran (Org 10172): its pharmacological profile in experimental models.
Orgaran is a mixture of glycosaminoglycans extracted from animal mucosa. It consists of heparan, dermatan and chondroitin sulfate… 
1991
1991
The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
We report two cases of heparin induced thrombocytopenia (HIT), in patients who required anticoagulation for extracorporeal… 
1991
1991
The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172.
1. We have investigated the effect of repeated s.c. Org 10172 (a low molecular weight heparinoid; Lomoparan) treatment (1000 anti… 
1990
1990
A new Low Molecular Weight Heparinoid Org 10172 as Anticoagulant in Hemodialysis
A low molecular weight heparinoid (Org 10172) was compared with unfractionated heparin in 36 patients on chronic hemodialysis in… 
1986
1986
The Anticoagulant Effect of Heparinoid Org 10172 During Haemodialysis: An Objective Assessment
Summary The heparinoid of natural origin Org 10172 has anti-factor Xa activity but minimal anti-thrombin activity, and little… 
1986
1986
Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid org 10172
Four patients with acute promyelocytic leukemia (APL) and clinical and laboratory manifestations of disseminated intravascular… 
1983
1983
The effects of antithrombin III, heparin and a novel heparinoid infusions on the bleeding tendency using an experimental model in the rat.
Review
1982
Review
1982
A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)